Cybin bags breakthrough tag for psychedelic depression drug
pharmaphorum
MARCH 14, 2024
Cybin files a $150m placement on the back of new clinical data with its psychedelic drug CYB003 for depression and an FDA breakthrough designation.
tag psychedelics 
110 
Let's personalize your content